Loading clinical trials...
Loading clinical trials...
An Open-label, Single-arm, Multicenter Phase 4 Study to Evaluate Safety and Tolerability of Romosozumab (EVENITY® ) in Postmenopausal Women in India With Osteoporosis and a High Risk of Fracture.
Conditions
Interventions
Romosozumab
Locations
10
India
Stavya Spine Hospital and Research Institute SSHRI
Ahmedabad, Gujarat, India
MS Ramaiah Medical College and Hospitals
Bangalore, Karnataka, India
King Edward Memorial Hospital And Seth Gordhandas Sunderdas Medical College
Mumbai, Maharashtra, India
Sancheti Institute for Orthopedics and rehabilitation
Pune, Maharashtra, India
Sir Ganga Ram Hospital
New Delhi, National Capital Territory of Delhi, India
Apollo Hospital
New Delhi, National Capital Territory of Delhi, India
Start Date
October 30, 2023
Primary Completion Date
October 18, 2025
Completion Date
October 18, 2025
Last Updated
November 3, 2025
NCT06767150
NCT05902078
NCT05010590
NCT07329543
NCT05060380
NCT04934072
Lead Sponsor
Amgen
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions